Provider
Rad AI's genAI tools will be offered through Bayer's vendor-neutral Calantic Digital Solution marketplace, which provides AI-enabled clinical and operational applications.
Fabric will use MeMD's virtual urgent, behavioral and primary care offerings to expand its employer-focused strategy.
Also, insurtech company Huize from China is expanding to Southeast Asia.
The company will use the funds to expand its employer-focused offerings into Florida.
LifeSemantics plans to commercialise its mobile app-based AI screening solution by yearend.
EvolutionaryScale's biology-focused language models for drug discovery and therapeutic development will be available to AWS customers.
The New York-based company will use the funds to grow its team, continue expanding into health systems and accelerate product innovation.
The acquisition will see the publicly traded healthcare-navigation company become a privately held business.
The acquisition will allow the fertility and family-building company to provide its services in more than 100 countries and in over 225 languages.
Interestingly, young physicians see more risk to it than their senior counterparts.